Both in Diagnostics
Alpha Teknova vs Celldex Therapeutics
Over the past year TKNO returned +55.2% and CLDX returned +25.5%; their daily moves had a correlation of 0.14.
TKNO +55.2% CLDX +25.5%Growth of $1, one year, split-adjusted
| Metric | TKNO | CLDX |
|---|---|---|
| Price | $7.37 | $29.93 |
| Market cap | $454.7M | $2.35B |
| Today | +0.41% | +0.74% |
| 1 month | −15.8% | −3.5% |
| 6 months | +102.5% | −13.0% |
| Year to date | +93.9% | +10.2% |
| 1 year | +45.1% | +20.9% |
| Revenue growth (YoY) | +18.5% | −97.0% |
| Gross margin | 40.1% | 100.0% |
| Net margin | −26.0% | −334104.5% |
| P/E (TTM) | — | — |
| Price / sales | 10.4× | 14,875.9× |
| Net cash | $4.2M | $717.6M |
| Dividend yield | — | — |
| Volatility (60d) | 79.6% | 47.7% |
| Short % of float | 19.5% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).